Carlsmed fetches $30m Series B
Carlsmed, a creator of spine fusion devices, has secured $30 million in Series B funding.
Carlsmed, a creator of spine fusion devices, has secured $30 million in Series B funding.
Copyright PEI Media
Not for publication, email or dissemination